lu 135252 has been researched along with Body Weight in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dieterich, M; Kossmehl, P; Kreutz, R; Rothermund, L; Traupe, T; Yagil, C; Yagil, Y | 1 |
Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M | 1 |
Nathan, T; Rose, T; Simoni, J; Tran, RM; Wesson, DE | 1 |
Amann, K; Banas, B; Orth, SR; Ritz, E; Schiele, G | 1 |
Amann, K; Esslinger, JP; Orth, SR; Raschack, M; Ritz, E; Schwarz, U | 1 |
Barton, M; d'Uscio, LV; Lüscher, TF; Moreau, P; Shaw, S | 1 |
Aus Dem Spring, C; Bollig, K; Dhein, S; Hochreuther, S; Hufnagel, C; Raschack, M | 1 |
deGottardi, A; Enseleit, F; Hürlimann, D; Lüscher, TF; Noll, G; Quaschning, T; Rossier, MF; Ruschitzka, F; Shaw, SG | 1 |
Aadahl, P; Arbo, I; Ellingsen, O; Loennechen, JP; Nilsen, OG; Nilsen, T; Sandvik, AK; Waldum, HL | 1 |
9 other study(ies) available for lu 135252 and Body Weight
Article | Year |
---|---|
Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension.
Topics: Albuminuria; Animals; Body Weight; Desoxycorticosterone; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Osteopontin; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sialoglycoproteins; Sodium; Sodium Chloride, Dietary | 2003 |
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta | 2004 |
Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production.
Topics: Acidosis, Renal Tubular; Acids; Animals; Bicarbonates; Body Weight; Bosentan; Caseins; Dietary Proteins; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides | 2007 |
Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain.
Topics: Animals; Aorta, Thoracic; Arterioles; Blood Pressure; Body Weight; Cardiovascular System; Disease Models, Animal; Endothelin A Receptor Antagonists; Genetic Predisposition to Disease; Hypertrophy; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Stroke; Tunica Media; Ventricular Remodeling | 2007 |
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Sodium, Dietary | 1998 |
Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Endothelin Receptor Antagonists; Endothelin-1; Heart; Kidney; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A | 1998 |
Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Blood Vessels; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Endothelin Receptor Antagonists; Endothelium, Vascular; Erythrocytes; Heart Rate; Indoles; Kidney Function Tests; Male; Muscle, Smooth, Vascular; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A | 2000 |
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acetylcholine; Animals; Blood Pressure; Body Weight; Cells, Cultured; Corticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Glycyrrhizic Acid; Heart Rate; Humans; Hydroxysteroid Dehydrogenases; Hypertension; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Phenylpropionates; Potassium Chloride; Protein Precursors; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Vascular Diseases; Vasoconstriction; Vasodilation; Vasodilator Agents; Verapamil | 2001 |
Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
Topics: Animals; Atmosphere Exposure Chambers; Atrial Natriuretic Factor; Body Weight; Carbon Monoxide; Cardiomegaly; Endothelin Receptor Antagonists; Endothelin-1; Female; Nicotine; Nicotinic Agonists; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger | 2002 |